Evidence map›Paper›PMID 17659705›Full record

ReviewWorld journal of gastroenterology2007

Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Andrea Morgner, Renate Schmelz, Christian Thiede, Manfred Stolte, Stephan Miehlke

Registry-linked trialAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01583699 (Confocal Laser Endomicroscopy as Diagnostic Tool for Gastrointestinal MALT-lymphoma), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01583699 nacompletednot on this mapstarted 2012, after this paper: background citation

Confocal Laser Endomicroscopy as Diagnostic Tool for Gastrointestinal MALT-lymphoma

TypeinterventionalSponsorMedical University of ViennaRan2012 to 2014Enrolled50ConditionsMALT-lymphomaArmsConfocal laser endomicroscopy, Confocal Laser Endomicroscope
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. H pylori: Treatment for the patient only or the whole family?World journal of gastroenterology · 2008
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.Mediterranean journal of hematology and infectious diseases · 2016
    Review
  7. Molecular oncology testing in resource-limited settings.The Journal of molecular diagnostics : JMD · 2014
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Rituximab in the treatment of non-Hodgkin's lymphoma.Biologics : targets & therapy · 2008
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrea MorgnerMedical Department I, University Hospital, Technical University Dresden, Germany. andrea.morgner-miehlke@uniklinikum-dresden.de
Renate Schmelz
Christian Thiede
Manfred Stolte
Stephan Miehlke
TU Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric mucosa associated lymphoid tissue (MALT) lymphoma has recently been incorporated into the World Health Organization (WHO) lymphoma classification, termed as extranodal marginal zone B-cell lymphoma of MALT-type. In about 90% of cases this lymphoma is associated with H pylori infection which has been clearly shown to play a causative role in lymphomagenesis. Although much knowledge has been gained in defining the clinical features, natural history, pathology, and molecular genetics of the disease in the last decade, the optimal treatment approach for gastric MALT lymphomas, especially locally advanced cases, is still evolving. In this review we focus on data for the therapeutic, stage dependent management of gastric MALT lymphoma. Hence, the role of eradication therapy, surgery, chemotherapy and radiotherapy is critically analyzed. Based on these data, we suggest a therapeutic algorithm that might help to better stratify patients for optimal treatment success.

Indexed as

Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsCombined Modality TherapyHelicobacter InfectionsHelicobacter pyloriHumansLymphoma, B-Cell, Marginal ZoneNeoplasm StagingOrganoplatinum CompoundsOxaliplatinRadiotherapyRituximabStomach NeoplasmsAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsOrganoplatinum CompoundsOxaliplatinRituximab

Identifiers

PMID17659705
PMCPMC4146794
OpenAlexW2106836929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.